ArriVent BioPharma, Inc.
AVBP
$24.10
$1.225.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 300.27M | 235.69M | 176.08M | 218.86M | 282.86M |
| Total Receivables | 505.00K | 505.00K | 505.00K | 500.00K | 500.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 552.00K | 787.00K | 1.23M | 407.00K | 1.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 19.90M | 13.17M | 7.98M | 7.21M | 7.90M |
| Total Current Assets | 321.22M | 250.15M | 185.79M | 226.98M | 292.40M |
|
|
|||||
| Total Current Assets | 321.22M | 250.15M | 185.79M | 226.98M | 292.40M |
| Net Property, Plant & Equipment | 49.00K | 85.00K | 120.00K | 154.00K | 187.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 180.00K | 479.00K | 176.00K | 126.00K | 126.00K |
| Total Assets | 326.56M | 269.51M | 215.50M | 274.94M | 292.71M |
|
|
|||||
| Total Accounts Payable | 5.93M | 4.06M | 4.36M | 3.78M | 4.65M |
| Total Accrued Expenses | 15.57M | 15.48M | 8.45M | 13.33M | 10.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 56.00K | 98.00K | 138.00K | 162.00K | 157.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.56M | 19.64M | 12.95M | 17.27M | 15.16M |
|
|
|||||
| Total Current Liabilities | 21.56M | 19.64M | 12.95M | 17.27M | 15.16M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 14.00K | 56.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.56M | 19.64M | 12.95M | 17.29M | 15.22M |
|
|
|||||
| Common Stock & APIC | 673.89M | 584.01M | 505.28M | 496.20M | 495.19M |
| Retained Earnings | -369.10M | -334.12M | -302.72M | -238.33M | -217.70M |
| Treasury Stock & Other | 206.00K | -18.00K | -17.00K | -211.00K | -- |
| Total Common Equity | 305.00M | 249.87M | 202.54M | 257.65M | 277.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 305.00M | 249.87M | 202.54M | 257.65M | 277.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 305.00M | 249.87M | 202.54M | 257.65M | 277.49M |
|
|
|||||